Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04494295 · ClinicalTrials.gov registry record
The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation
A clinical trial of Supratentorial Hemorrhage, sponsored by Integra LifeSciences Corporation.
- Recruiting
- Registry status
- 500
- Enrollment target
- 20
- Study locations
NCT04494295 is a study of Supratentorial Hemorrhage that is actively recruiting participants, run by Integra LifeSciences Corporation. The registered enrollment target is 500 participants. The trial reports 20 study locations across 16 states.
The verdict
NCT04494295, a study of Supratentorial Hemorrhage, is actively recruiting participants, sponsored by Integra LifeSciences Corporation.
- RECRUITING
- Registry status
- 500 participants
- Enrollment target
- 20
- Study locations
Study Summary
This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery from last known well time will be explored.
Conditions Studied
Interventions
- DEVICE Aurora Surgiscope System
Study Locations (20)
Florida
- University of Miami - Miami
- University of South Florida - Tampa
Missouri
- University of Missouri - Columbia
- Washington University in St. Louis - St Louis
New York
- University at Buffalo - Buffalo
- Icahn School of Medicine at Mount Sinai - New York
Pennsylvania
- Pennsylvania State University - Hershey
- University of Pennsylvania - Philadelphia
California
- Providence Health - Burbank
Illinois
- Rush University Medical Center - Chicago
Maryland
- MedStar Health Research Institute - Baltimore
Michigan
- Corewell Health - Grand Rapids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 500 participants |
| Start Date | 2020-10-23 |
| Est. Completion | 2029-10-15 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04494295
The ClinicalTrials.gov registry entry for NCT04494295 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 500 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Integra LifeSciences Corporation, which has 60 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Supratentorial Hemorrhage appearing as the primary indexed condition, and to 1 intervention - of which Aurora Surgiscope System is the first listed.
NCT04494295 reports 20 study locations spanning 16 distinct geographic areas - top geographies include Florida, Missouri, New York.
Frequently Asked Questions
What is clinical trial NCT04494295 about?
NCT04494295 is a clinical study titled "The MIRROR Registry: Minimally Invasive IntRaceRebral HemORrhage Evacuation". This registry will study the use of the Aurora® Surgiscope to provide surgical access and visualization in minimally invasive removal of hematoma in the brain. Many methods of hematoma removal are available and will be based on surgeon preference. The impact of patient selection and time to surgery ...
What is the current status of trial NCT04494295?
This trial is currently recruiting. The enrollment target is 500 participants. The study started on 2020-10-23. Estimated completion is 2029-10-15.
What conditions does trial NCT04494295 study?
This clinical trial studies the following conditions: Supratentorial Hemorrhage.
What interventions are being tested in trial NCT04494295?
The interventions under investigation include: Aurora Surgiscope System (DEVICE).
Who is sponsoring clinical trial NCT04494295?
This trial is sponsored by Integra LifeSciences Corporation, which has 60 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04494295 being conducted?
This trial has 20 study locations across California, Florida, Illinois, Maryland, Michigan. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.